Reuters logo
BRIEF-Hemispherx Biopharma announces extension of Rintatolimod European early access program
January 11, 2017 / 1:54 PM / a year ago

BRIEF-Hemispherx Biopharma announces extension of Rintatolimod European early access program

Jan 11 (Reuters) - Hemispherx Biopharma Inc :

* Hemispherx Biopharma announces extension of Rintatolimod European early access program (eap) to pancreatic cancer patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below